TipRanks
Innate Pharma (IPHA)
NASDAQ:IPHA
Want to see IPHA full AI Analyst Report?

Compare Innate Pharma (IPHA) vs. Competitors

152 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$2.27
$183.10M
-2.78
-4.49%
3 Buy
0 Hold
0 Sell
Strong Buy
SELLAS Life Sciences Group
$14.09
$2.34B
-54.85
611.04%
2 Buy
0 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$3.01
$48.36M
-0.87
-83.18%
2 Buy
1 Hold
0 Sell
Moderate Buy
Vor Biopharma
$24.01
$1.10B
-0.06
-45.54%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.70
-0.23
-11.92%
SLS
SELLAS Life Sciences Group
11.59
9.98
619.88%
SGMO
―
―
―
―
GNFT
―
―
―
―
ELTX
Elicio Therapeutics
1.85
-9.09
-83.09%
VOR
Vor Biopharma
18.31
-30.41
-62.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts